Similar title :
– Sarepta Increases Sales in 2021 Forecast of $ 40 Million of Strong Muscular Dystrophy Drugs Sales
– Sarepta Therapeutics Announces Third Quarter 2021 Financial Results and Latest Company Developments
– Sarepta Therapeutics Reports Q3 Net Product Sales of 166.9 million USD
Keywords: